Page last updated: 2024-09-05

ly 300164 and Astrocytoma, Grade IV

ly 300164 has been researched along with Astrocytoma, Grade IV in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Batchelor, T; Chamberlain, M; Desideri, S; Fine, HA; Fisher, J; Grossman, SA; Mikkelsen, T; Piantadosi, S; Ye, X1
Desideri, S; Fisher, J; Grossman, SA; Nabors, LB; Piantadosi, S; Rosenfeld, M; Ye, X1

Trials

1 trial(s) available for ly 300164 and Astrocytoma, Grade IV

ArticleYear
Talampanel with standard radiation and temozolomide in patients with newly diagnosed glioblastoma: a multicenter phase II trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009, Sep-01, Volume: 27, Issue:25

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Benzodiazepines; Brain Neoplasms; Cranial Irradiation; Dacarbazine; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Excitatory Amino Acid Antagonists; Female; Glioblastoma; Humans; Kaplan-Meier Estimate; Karnofsky Performance Status; Male; Middle Aged; Proportional Hazards Models; Radiotherapy, Adjuvant; Receptors, AMPA; Risk Assessment; Temozolomide; Time Factors; Treatment Outcome; Tumor Suppressor Proteins; United States

2009

Other Studies

1 other study(ies) available for ly 300164 and Astrocytoma, Grade IV

ArticleYear
Survival of patients with newly diagnosed glioblastoma treated with radiation and temozolomide in research studies in the United States.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2010, Apr-15, Volume: 16, Issue:8

    Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Benzodiazepines; Biomedical Research; Brain Neoplasms; Carboxymethylcellulose Sodium; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Cranial Irradiation; Dacarbazine; Drug Therapy, Combination; Female; Glioblastoma; Humans; Interferon Inducers; Male; Middle Aged; Poly I-C; Polylysine; Receptors, AMPA; Snake Venoms; Survival Rate; Temozolomide; Treatment Outcome; United States; Young Adult

2010